Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease

Chronic Respiratory Disease

Volumn 2, Issue 4, 2005, Pages 183-191

  Schlecht, N F ^a,b   Schwartzman, K ^a,c   Bourbeau, Jean ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Anxiety; Breathlessness; Chronic obstructive pulmonary disease; Depression; Dyspnea; Quality of life

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSOCIAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; SPIROMETRY;

AGED; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS INDICATORS; HUMANS; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 27344445330     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1191/1479972305cd079oa     Document Type: Article

References (59)

1. Mahler DA, Rosiello RA, Harver A, Lentine T, McGovern JF, Daubenspeck JA. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 1987; 135: 1229-33.
2. Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis 1986; 134: 1129-34.
3. Gift AG, Cahill CA. Psychophysiologic aspects of dyspnea in chronic obstructive pulmonary disease: a pilot study. Heart Lung 1990; 19: 252-57.
4. Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J 1997; 10: 1581-84.
5. Guyatt GH, Townsend M, Berman LB, Pugsley SO. Quality of life in patients with chronic airflow limitation. Br J Dis Chest 1987; 81: 45-54.
6. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116: 1632-37.
7. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 841-46.
8. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-86.
9. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1726-34.
10. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-40.
11. O'Donnell DE, Aaron S, Bourbeau J et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2003. Can Respir J 2003; 10 (Suppl A): 11A-65A.
12. Medical Research Council Committee on the Aetiology of Chronic Bronchitis. Standardized questionnaires on respiratory symptoms. Br Med J 1960; 2: 1665.
13. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978; 118: 1-120.
14. Speizer F, Comstock G. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978; 118: 7-53.
15. Celli BR. The importance of spirometry in COPD and asthma: effect on approach to management. Chest 2000; 117 (2 Suppl): 15S-19S.
16. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 1978; 2: 241-43.
17. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-78.
18. Wijnhoven HA, Kriegsman DM, Hesselink AE, Penninx BW, de Haan M. Determinants of different dimensions of disease severity in asthma and COPD: pulmonary function and health-related quality of life. Chest 2001; 119: 1034-42.
19. Hnizdo E, Churchyard G, Barnes D, Dowdeswell R. Assessment of reliability of lung function screening programs or longitudinal studies. Am J Respir Crit Care Med 1999; 160: 2006-11.
20. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976; 113: 587-600.
21. Osterman JW, Armstrong BG, Ledoux E, Sloan M, Ernst P. Comparison of French and English versions of the American Thoracic Society respiratory questionnaire in a bilingual working population. Int J Epidemiol 1991; 20: 138-43.
22. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-44.
23. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982; 284: 1607-608.
24. Guyatt GH, Sullivan MJ, Thompson PJ et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-23.
25. Endler NS, Parker JDA. Coping inventory for stressful situations. UC. Toronto, ON: Multi-Health Systems, Inc., 1992.
26. Spielberger CD. State-trait anxiety inventory (form X). Palo Alto, CA: Consulting Psychologists Press, Inc., 1983.
27. McCrae RR, Costa PT, Jr. Validation of the five-factor model of personality across instruments and observers. J Pers Soc Psychol 1987; 52: 81-90.
28. Costa PT, Jr, McCrae RR. Revised NEO personality inventory (NEO PI-R) and NEO five-factor inventory (NEO-FFI): professional manual. Odessa, FL: Psychological Assessment Resources, Inc., 1991.
29. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-27.
30. Bourbeau J, Maltais F, Rouleau M, Guimont C. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J 2004; 11: 480-86.
31. Bourbeau J, Guimont C, Gibbons W et al. Validation of french translated chronic respiratory questionnaire (CRQ) in patients with chronic obstructive pulmonary disease (COPD). ALA/ATS International Conference. 24-29 April 1998. AJRCCM: American Thoracic Society, 1998: 605.
32. Bergeron J. State-trait anxiety in French-English bilinguals: cross-cultural considerations. Series in Clin & Community Psych: Stress & Anxiety 1983; 2: 157-76.
33. Endler N, Parker J. Coping inventory for stressful situations manual. North Tonawanda, NY: MHS/Multi-Health Systems, Inc., 1990.
34. Vezina J. Questionnaire de depression de Beck: etude psychometrique aupres d'une population agee francophone. Can J on Aging 1991; 10: 29-39.
35. Tilden VP, Nelson CA, May BA. The IPR inventory: development and psychometric characteristics. Nurs Res 1990; 39: 337-43.
36. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85 (Suppl B): 25-31; discussion 33-37.
37. Beck AT. Beck depression inventory manual. San Antonio, TX: Psychological Corp.: Harcourt Brace & Co., 1993; 24.
38. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariate methods, 2nd edn. Belmont, CA: PWS-KENT Publishing Co., 1988.
39. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145: 467-70.
40. Moody L, McCormick K, Williams AR. Psychophysiologic correlates of quality of life in chronic bronchitis and emphysema. West J Nurs Res 1991; 13: 336-47.
41. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-17.
42. Turner SE, Eastwood PR, Cecins NM, Hillman DR, Jenkins SC. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest 2004; 126: 766-73.
43. Ciccone AM, Meyers BF, Guthrie TJ et al. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg 2003; 125: 513-25.
44. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185-89.
45. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580-86.
46. Dales RE, Spitzer WO, Schechter MT, Suissa S. The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis 1989; 139: 1459-63.
47. Wolkove N, Dajczman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989; 96: 1247-51.
48. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994; 7: 725-29.
49. Renfroe KL. Effect of progressive relaxation on dyspnea and state anxiety in patients with chronic obstructive pulmonary disease. Heart & Lung 1988, 17: 408-13.
50. Gift AG, Plaut SM, Jacox A. Psychologic and physiologic factors related to dyspnea in subjects with chronic obstructive pulmonary disease. Heart Lung 1986; 15: 595-601.
51. Burns BH, Howell JB. Disproportionately severe breathlessness in chronic bronchitis. Quarterly Journal of Medicine 1969; 38: 277-94.
52. Moody L, McCormick K, Williams A. Disease and symptom severity, functional status, and quality of life in chronic bronchitis and emphysema (CBE). J Behav Med 1990; 13: 297-306.
53. Costa PT, Jr, McCrae RR. Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Pers Soc Psychol 1988; 54: 853-63.
54. Sassi-Dambron DE, Eakin EG, Ries AL, Kaplan RM. Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies. Chest 1995; 107: 724-29.
55. Lacasse Y, Guyatt GH, Goldstein RS. The components of a respiratory rehabilitation program: a systematic overview. Chest 1997; 111: 1077-88.
56. Wiebe JS, Christensen AJ. Health beliefs, personality, and adherence in hemodialysis patients: an interactional perspective. Ann Behav Med 1997; 19: 30-35.
57. Antonelli-Incalzi R, Imperiale C, Bellia V et al. Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 2003; 22: 444-49.
58. Aaron SD, Vandemheen KL, Clinch JJ et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002; 121: 688-96.
59. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 785-90.